Poster ARVO 2017 Batimore USA

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study
Maddalena Quaranta,François Devin,Gabriel Quentel,Joël Uzzan, Eric Fourmaux, Laurent Castelnovo,Wilfried Roquet,Catherine Francais-Maury,Sam Razavi,Nathalie San Nicolas

 

https://www.dropbox.com/s/6pxwf3j1vo38dpd/Poster%20Oracle%20ARVO%202017.pdf?dl=0